Pharma Mar SA
MAD:PHM

Watchlist Manager
Pharma Mar SA Logo
Pharma Mar SA
MAD:PHM
Watchlist
Price: 78.85 EUR -1.25% Market Closed
Market Cap: 1.4B EUR
Have any thoughts about
Pharma Mar SA?
Write Note

Pharma Mar SA
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Pharma Mar SA
Total Liabilities & Equity Peer Comparison

Comparables:
GRF
ORY
BST

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Pharma Mar SA
MAD:PHM
Total Liabilities & Equity
€317.1m
CAGR 3-Years
-3%
CAGR 5-Years
20%
CAGR 10-Years
4%
Grifols SA
MAD:GRF
Total Liabilities & Equity
€21.4B
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Oryzon Genomics SA
MAD:ORY
Total Liabilities & Equity
€106.9m
CAGR 3-Years
4%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Biotechnology Assets SA
MAD:BST
Total Liabilities & Equity
€16.6m
CAGR 3-Years
-6%
CAGR 5-Years
-27%
CAGR 10-Years
N/A

See Also

What is Pharma Mar SA's Total Liabilities & Equity?
Total Liabilities & Equity
317.1m EUR

Based on the financial report for Jun 30, 2024, Pharma Mar SA's Total Liabilities & Equity amounts to 317.1m EUR.

What is Pharma Mar SA's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
4%

Over the last year, the Total Liabilities & Equity growth was -12%. The average annual Total Liabilities & Equity growth rates for Pharma Mar SA have been -3% over the past three years , 20% over the past five years , and 4% over the past ten years .

Back to Top